SS

Sudha Singh

Active Director Director DIN 07294965
DIN 07294965 First appointment Oct 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Sudha Singh

Data last updated:

Sudha Singh is a Director at Shashank Medi Pharma Private Limited (since 2015). The company operates in Pharma. Shashank Medi Pharma Private Limited reported revenue of ₹17.3 Lakh (FY 2020).

DIN 07294965
Primary Designation Director
Industry Pharma
First Appointment 01 Oct 2015
Oldest Company Age 11 yrs
Largest company Shashank Medi Pharma Private Limited · ₹17.3 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shashank Medi Pharma Private Limited U74120UP2015PTC073617
Director01 Oct 20152015₹17.3 Lakh (FY 2020)Active

Board colleagues of Sudha Singh

Directorship timeline

Open interactive timeline →
Shashank Medi Pharma Private Limited
Premium access

Shareholding and investment profile for Sudha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudha Singh

Sudha Singh currently holds 1 directorship: Shashank Medi Pharma Private Limited (Director, since 01 Oct 2015, revenue ₹17.3 Lakh (FY 2020)).

Sudha Singh was first appointed on 01 Oct 2015 as Director at Shashank Medi Pharma Private Limited.

The current boards of Sudha Singh's companies include Jitendra Kumar Singh (Shashank Medi Pharma Private Limited), Ram Milan Singh (Shashank Medi Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available